Dr. Maggie E. Fader
Claim this profileNicklaus Children's Hospital
Studies Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
13 reported clinical trials
37 drugs studied
Area of expertise
1Leukemia
Philadelphia chromosome positive
BCR-ABL1 fusion positive
ABL-class fusion positive
2Lymphoblastic Leukemia-Lymphoma
Philadelphia chromosome positive
BCR-ABL1 fusion positive
ABL-class fusion positive
Affiliated Hospitals
Clinical Trials Maggie E. Fader is currently running
DAY101
for Langerhans Cell Histiocytosis
This trial tests the safety and effectiveness of tovorafenib (DAY101) in children and young adults with Langerhans cell histiocytosis that is worsening, has returned, or does not respond to other treatments. Tovorafenib is taken orally and works by blocking enzymes needed for cancer cell growth. The study aims to find the best dose and observe the response and side effects over time.
Recruiting1 award Phase 228 criteria
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
More about Maggie E. Fader
Clinical Trial Related1 year of experience running clinical trials · Led 13 trials as a Principal Investigator · 12 Active Clinical TrialsTreatments Maggie E. Fader has experience with
- Cyclophosphamide
- Etoposide
- Dactinomycin
- Vincristine
- Doxorubicin
- Carboplatin
Breakdown of trials Maggie E. Fader has run
Leukemia
Lymphoblastic Leukemia-Lymphoma
Acute Lymphoblastic Leukemia
Lymphoid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maggie E. Fader specialize in?
Maggie E. Fader focuses on Leukemia and Lymphoblastic Leukemia-Lymphoma. In particular, much of their work with Leukemia has involved Philadelphia chromosome positive patients, or patients who are BCR-ABL1 fusion positive.
Is Maggie E. Fader currently recruiting for clinical trials?
Yes, Maggie E. Fader is currently recruiting for 12 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Maggie E. Fader has studied deeply?
Yes, Maggie E. Fader has studied treatments such as Cyclophosphamide, Etoposide, Dactinomycin.
What is the best way to schedule an appointment with Maggie E. Fader?
Apply for one of the trials that Maggie E. Fader is conducting.
What is the office address of Maggie E. Fader?
The office of Maggie E. Fader is located at: Nicklaus Children's Hospital, Miami, Florida 33155 United States. This is the address for their practice at the Nicklaus Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.